Partners to develop next-generation sequencing-based cancer diagnostics, to accelerate clinical research into oncology and immuno-oncology
VENTANA PD-L1 (SP142) Assay is a companion diagnostic for Tecentriq + Abraxane, the first immunotherapy regimen approved for breast cancer.
HTG's year-old collaboration with Merck KGaA now includes a complementary focus on translational programs as well as companion diagnostics.
Pathogenic gut bacteria that migrate to the pancreas via the pancreatic duct shut down the immune system and promote tumor growth
Researchers use data from 275,000 women for a genome-wide association study that found seven variants specific to ER-negative breast cancer
Sequencing giant, research institute also commit to establishing partnerships with hospitals and research institutions in China and Africa.
The campus will house Qiagen’s planned European Centre of Excellence for Precision Medicine and hub for diagnostics development
Companion diagnostics are bridging the gap between molecular diagnostics and therapeutics, helping to ensure that the right drug is provided to the right patient...
Thermo Fisher Scientific completed the listing of its Ion PGM Dx next-generation sequencing (NGS) system with the FDA for clinical use as a class...
Call them the guardians of the gut microbiome: bacteria that are associated with protection against food allergies. Such bacteria, “good” bacteria, have been identified...